How Blockchain Can Boost Your Health
HONG KONG, CHINA / ACCESSWIRE / June 6, 2019 / Young, elderly, man, woman, dumb, wise, rich or poor no...
HONG KONG, CHINA / ACCESSWIRE / June 6, 2019 / Young, elderly, man, woman, dumb, wise, rich or poor no...
ATLANTA, GA / ACCESSWIRE / June 5, 2019 / Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled...
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 CHARLOTTESVILLE, VA / ACCESSWIRE / June 6, 2019...
DECN Awaits Major Proposition On Or About June 10, Notifies Two Entities That Their Earlier Propositions Do Not Meet Requirements,...
Shares of Common Stock to Begin Trading on Split-Adjusted Basis on June 7, 2019 SAN FRANCISCO, CA / ACCESSWIRE /...
ROGGWIL, SWITZERLAND / ACCESSWIRE / June 5, 2019 / Resaphene Suisse AG, ISIN CH0367465439, WKN A2JG91, has been notified of...
Report highlights input from 20 leading healthcare CISOs who offer their perspective on evolving cyberattacks, ransomware and the biggest concerns...
SAN FRANCISCO, CA / ACCESSWIRE / June 5, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
SAN DIEGO, CA, and CALGARY, AB / ACCESSWIRE / June 5, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC),...
Phase 2 BRACELET-1 study to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and anti-PD-L1 antibody avelumab...
LONDON, UK / ACCESSWIRE / June 5, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces the first data results from...
ANGLE plc ("the Company") SUCCESSFUL COMPLETION OF OVARIAN CANCER PRE-STUDY Pre-study demonstrates ANGLE's optimised sample-to-answer molecular solution with patient samples...
INCLUDING NEW CELL TYPES SUPPORTS DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS $ 9.0 M PAYMENT TO EVOTEC HAMBURG,...
LOS ANGELES, CA / ACCESSWIRE / June 4, 2019 / NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a regenerative medicine...
Annual Awards Program Recognizes Outstanding Digital Health & Medical Technology Products and CompaniesASHTEAD, UK – June 4, 2019 – BridgeHead...
LIVINGSTON, NJ / ACCESSWIRE / June 4, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the shares...
Initial Purchase by Beijing Dahua Sanxin Technology Development Co., Ltd. Represents First MiOXSYS Commercial Sale in China. ENGLEWOOD, CO /...
SAN CLEMENTE, CA / ACCESSWIRE / June 4, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Expands Market Presence in Asia Pacific Region REDWOOD CITY, CA / ACCESSWIRE / June 4, 2019 / Avinger, Inc. (NASDAQ:...
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 is 50- to 300-fold more potent than approved PDE4 inhibitors Phase...